New York Post
A new study has found that the antimalarial drug hydroxychloroquine helped COVID-19 patients better survive in the hospital.
A team at Henry Ford Health System in southeast Michigan said Thursday that a study of 2,541 hospitalized patients found that those given the drug were far less likely to die, CNN reported.
Dr. Marcus Zervos, the system’s division head of infectious disease, said 26 percent of those not given hydroxychloroquine died, compared to 13 percent of those who got the drug.
“Overall crude mortality rates were 18.1 percent in the entire cohort, 13.5 percent in the hydroxychloroquine alone group, 20.1 percent among those receiving hydroxychloroquine plus azithromycin, 22.4 percent among the azithromycin alone group, and 26.4 percent for neither drug,” the team wrote in a report published in the International Journal of Infectious Diseases.